HAEMATO AG (HAM:HAEK)

Germany flag Germany · Delayed Price · Currency is EUR
13.00
0.00 (0.00%)
At close: Jun 10, 2026
Market Cap67.96M +5.7%
Revenue (ttm)260.81M +2.5%
Net Income9.61M +2,578.0%
EPS1.88 +2,605.8%
Shares Out 5.23M
PE Ratio6.93
Forward PEn/a
Dividend0.04 (0.31%)
Ex-Dividend DateJul 8, 2026
Volume1,850
Open12.90
Previous Close13.00
Day's Range12.90 - 13.00
52-Week Range8.20 - 13.60
Beta-0.01
Analystsn/a
Price Targetn/a
Earnings Daten/a

About HAEMATO AG

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases. Further, the company develops, manufactures, and distributes diagnostic tests under the HAEMATO... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1993
Employees 76
Stock Exchange Hamburg Stock Exchange
Ticker Symbol HAEK
Full Company Profile